Public Calendar: October 29, 2023 - November 4, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 10/31/2023
Location: Virtual
Subject: Pharmaceutical Quality Symposium 2023: Quality, Supply Chain, and Advanced Manufacturing; Speaker: Keynote Address
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, and other registered attendees

Event Date: 10/31/2023
Location: Virtual
Subject: Produce Safety Alliance Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jennifer Trodden, Richard Ball (New York State Department of Agriculture and Markets); Ted McKinney (National Association of State Departments of Agriculture);

Event Date: 11/02/2023
Location: Washington, DC
Subject: Grantmakers in Health 2023 Fall Forum; Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other registered attendees

Event Date: 11/02/2023
Location: Virtual
Subject: Meeting with Cancer Centers
FDA Participant/Group: ANDREW ZACHER;
Non FDA Participant/Group: Government and academia

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 10/30/2023
Location: Virtual
Subject: Introductory Meeting; Food Safety Issues of Mutual Interest
FDA Participant/Group: JANESIA ROBBS; LARRY MORRIS;
Non FDA Participant/Group: Emily Holubowich, Nancy Brown (American Heart Association);

Event Date: 10/31/2023
Location: Silver Spring, MD
Subject: Foods Program Issues of Mutual Interest
FDA Participant/Group: KARI BARRETT; DONALD PRATER; REBECCA BUCKNER; SUZANNE ROOSEN; LAURA PILLSBURY;
Non FDA Participant/Group: Roberta Wagner (International Dairy Foods Association); Brian Ronholm (Consumer Reports);

Event Date: 11/01/2023
Location: Washington, DC
Subject: Introductory Meeting; Food Safety Issues of Mutual Interest
FDA Participant/Group: MATTHEW LOCKEED;
Non FDA Participant/Group: Senator Richard Blumenthal (D-CT)

Event Date: 11/01/2023
Location: Virtual
Subject: National Confectioners Association Webinar; Keynote Speech: Human Foods Program Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and academia

Event Date: 11/02/2023
Location: Washington, DC
Subject: Introductory Meeting; Food Safety Issues of Mutual Interest
FDA Participant/Group: DANIEL HATTIS;
Non FDA Participant/Group: Representative Andy Harris (R-MD)

Event Date: 11/02/2023
Location: Virtual
Subject: Introductory Meeting; Food Safety Issues of Mutual Interest
FDA Participant/Group: CATHERINE MCDERMOTT; LARRY MORRIS; ERIK METTLER; JEFFREY FARRAR;
Non FDA Participant/Group: Katherine Simon, Liz Wirsing, Steven Mandernach (Association of Food and Drug Officials);

Event Date: 11/03/2023
Location: Virtual
Subject: Introductory Meeting; Added Sugars
FDA Participant/Group: CLAUDINE KAVANAUGH; JANESIA ROBBS; STACEY VIERA; LARRY MORRIS;
Non FDA Participant/Group: Campbell Genn, Courtney Gaine (The Sugar Association);

Event Date: 11/03/2023
Location: Virtual
Subject: Introductory Meeting; Food Safety Issues of Mutual Interest
FDA Participant/Group: DANIEL HATTIS;
Non FDA Participant/Group: Representative Rosa DeLauro (D-CT)

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 10/30/2023
Location: Silver Spring, MD
Subject: European Parliament's Subcommittee on Public Health Visit
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives of the European Parliament, World Health Organization, and European Union Mission to the United States

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 11/03/2023
Location: Virtual
Subject: Informal Introductory Meeting
FDA Participant/Group: JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Lucy Rose (Consultant - Former FDA);

Event Date: 11/03/2023
Location: Virtual
Subject: Critical Path Institute (C-PATH) / FDA Annual Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives of C-PATH

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/30/2023
Location: Arlington, VA
Subject: Indo - US Bridging RARE Summit 2023; Speaker: Advancing Rare Disease Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry (with a specific focus on the United States and the Indian subcontinent), research, healthcare, patient advocate, and government stakeholders

Event Date: 10/30/2023
Location: Rockville, MD
Subject: Maryland Tech Council’s Maryland Life Sciences Bio Innovation Conference; Speaker: Expediting the Development and Availability of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Life sciences professionals, industry, research, and academic stakeholders

Event Date: 11/01/2023
Location: Bethesda, MD
Subject: FDA - Alliance for Regenerative Medicine Scientific Exchange; Speaker: Pursuing the Long Tail of Rare Diseases and FDA Objectives
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academic, and regulatory stakeholders

Event Date: 11/02/2023
Location: New York, NY
Subject: North America Rare Disease Summit 2023; Panelist: Advances in Rare Disease Diagnosis and Treatment-Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, government, regulatory, healthcare, and patient advocate stakeholders

Event Date: 11/02/2023
Location: New York, NY
Subject: North America Rare Disease Summit 2023; Panelist: Fostering Rare Disease Research and Innovation Uniting Efforts in North America
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, government, regulatory, healthcare, and patient advocate stakeholders

Event Date: 11/02/2023
Location: New York, NY
Subject: North America Rare Disease Summit 2023; Panelist: Addressing Management of Rare Diseases, Hospital Networks and Reference Centers
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, government, regulatory, healthcare, and patient advocate stakeholders

Event Date: 11/03/2023
Location: Virtual
Subject: Parenteral Drug Association West Coast Chapter’s Meet the FDA; Speaker: Advancing Rare Disease Gene Therapy; Panelist: Question and Answer Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, research, and regulatory stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 11/02/2023
Location: Silver Spring, MD
Subject: EndeavorRx and EndeavorOTC
FDA Participant/Group: DOUGLAS KELLY; WILLIAM MAISEL; VIVEK PINTO; DAVID MCMULLEN; JESSICA PAULSEN; PAMELA SCOTT; ANITA BAJAJ; DOE KUMSA; ROBERT KANG;
Non FDA Participant/Group: Matt Franklin, Walter Edward, Scott Kollins, and Jacqueline Studer (Akili Interactive); Janice Hogan (Hogan Lovells)

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 10/31/2023
Location: Beijing, China
Subject: One Health Landscape Meeting
FDA Participant/Group: JULIE MOSS; LIXIA WANG; ROY STEPHENS; CLINTON PRIESTLEY; TIMOTHY JACKSON; VANESSA SHAW DORE;
Non FDA Participant/Group: Several representatives from embassy missions and non-government organizations

Event Date: 11/01/2023
Location: Beijing, China
Subject: Republic of China GACC Bilateral Meeting
FDA Participant/Group: CLINTON PRIESTLEY; JULIE MOSS; ROY STEPHENS; TIMOTHY JACKSON; LIXIA WANG; ZIMEI FU;
Non FDA Participant/Group: Guo Xueyan, Kong Xiaobang, Meng Xianjin, Zhou Wen (General Administration of Customs of the People's Republic of China (GACC));

Event Date: 11/02/2023
Location: Beijing, China
Subject: China International Food and Safety Quality Conference; Speaker: Updates from the U.S. FDA
FDA Participant/Group: TIMOTHY JACKSON; JULIE MOSS;
Non FDA Participant/Group: Regulatory officials, food executives, scientists, and other stakeholders

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 11/02/2023
Location: Virtual
Subject: House Committee on Energy and Commerce Minority Briefing; FDA Tobacco Programmatic Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the House Committee on Energy and Commerce

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 10/30/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; ROXANNE SCHWEITZER; MATTHEW LUCIA;
Non FDA Participant/Group: Representatives of Elanco

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

Event Date: 11/02/2023
Location: Memphis, TN
Subject: St. Jude Pediatric Translational Neuroscience Initiative (PTNI) Workshop; Panelist
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia and industry

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event